Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO

Journal of Hazardous Materials

Volumn 239-240, Issue , 2012, Pages 64-69

  Dolar, Davor ^a,b   Gros, Meritxell ^b   Rodriguez Mozaz, Sara ^b   Moreno, Jordi ^b   Comas, Joaquim ^b   Rodriguez Roda, Ignasi ^b   Barceló, Damià ^b,c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF GIRONA   (Spain)

^c INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Emerging contaminants; Membrane bioreactor; Pharmaceutical; Removal from municipal wastewater; Reverse osmosis

Indexed keywords

ANTI-INFLAMMATORIES; ANTIPLATELET AGENT; AQUATIC ENVIRONMENTS; AVERAGE CONCENTRATION; EMERGING CONTAMINANT; FLUOROQUINOLONE ANTIBIOTICS; HIGH CONCENTRATION; LIVING ORGANISMS; MACROLIDE ANTIBIOTICS; MEMBRANE BIOREACTOR; MEMBRANE SYSTEM; METRONIDAZOLE; MUNICIPAL WASTEWATER TREATMENT PLANTS; MUNICIPAL WASTEWATERS; NITROIMIDAZOLES; OFLOXACIN; PILOT-SCALE MEMBRANES; POTENTIAL EFFECTS; RANITIDINE; RECEPTOR ANTAGONISTS; REMOVAL EFFICIENCIES; REMOVAL RATE; RO MEMBRANE;

BIOLOGY; CONTAMINATION; DRUG PRODUCTS; REVERSE OSMOSIS; SEWAGE TREATMENT PLANTS; SULFUR COMPOUNDS;

ANTIBIOTICS;

ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CODEINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCODONE; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE; OFLOXACIN; PSYCHOTROPIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE; SULFONAMIDE;

AQUATIC ENVIRONMENT; AQUEOUS SOLUTION; DRUG; MEMBRANE; MUNICIPAL SOLID WASTE; OSMOSIS; POLLUTANT REMOVAL; WASTE TREATMENT; WASTEWATER;

ARTICLE; MEMBRANE REACTOR; REVERSE OSMOSIS; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

ADSORPTION; BACTERIA; BIOREACTORS; MEMBRANES, ARTIFICIAL; OSMOSIS; PHARMACEUTICAL PREPARATIONS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

SPAIN;

EID: 84867720118     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.03.029     Document Type: Article

References (32)

1. Barnes K.K., Kolpin D.W., Furlong E.T., Zaugg S.D., Meyer M.T., Barber L.B. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States-I) groundwater. Sci. Total Environ. 2008, 402:192-200.
2. Terzić S., Senta I., Ahel M., Gros M., Petrović M., Barceló D., Müller J., Knepper T., Marti I., Ventura F., Jovančić P., Jabučar D. Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. Sci. Total Environ. 2008, 399:66-77.
3. Loos R., Gawlik B.M., Locoro G., Rimaviciute E., Contini S., Bidoglio G. EU-wide survey of polar organic persistent pollutants in European river waters. Environ. Pollut. 2009, 157:561-568.
4. Carballa M., Omil F., Lema J.M., Llompart M., Garciá-Jares C., Rodríguez I., Gómez M., Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004, 38:2918-2926.
5. Moon H-B., Yoon S-P., Jung R-H., Choi M. Wastewater treatment plants (WWTPs) as a source of sediment contamination by toxic organic pollutants and fecal sterols in a semi-enclosed bay in Korea. Chemosphere 2008, 73:880-889.
6. Rahman M.F., Yanful E.K., Jasim S.Y. Occurrence of endocrine disrupting compounds and pharmaceuticals in the aquatic environment and their removal from drinking water: challenges in the context of the developing world. Desalination 2009, 248:578-585.
7. Al-Odaini N.A., Zakaria M.P., Yaziz M.I., Surif S. Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2010, 1217:6791-6806.
8. Tam L.S., Tang T.W., Lau G.N., Sharma K.R., Chen G.H. A pilot study for wastewater reclamation and reuse with MBR/RO and MF/RO systems. Desalination 2007, 202:106-113.
9. Dialynas E., Diamadopoulos E. Integration of a membrane bioreactor coupled with reverse osmosis for advanced treatment of municipal wastewater. Desalination 2009, 238:302-311.
10. Sahar E., David I., Gelman Y., Chikurel H., Aharoni A., Messalem R., Brenner A. The use of RO to remove emerging micropollutants following CAS/UF or MBR treatment of municipal wastewater. Desalination 2011, 273:142-147.
11. 2 addition as scaling control. Water Res. 2011, 45:6141-6151.
12. Alturki A.A., Tadkaew N., McDonald J.A., Khan S.J., Price W.E., Nghiem L.D., Combining M.B.R NF/RO membrane filtration for the removal of trace organics in indirect potable water reuse applications. J. Membr. Sci. 2010, 365:206-215.
13. Monclús H., Sipma J., Ferrero G., Rodriguez-Roda I., Comas J. Biological nutrient removal in an MBR treating municipal wastewater with special focus on biological phosphorus removal. Bioresour. Technol. 2010, 101:3984-3991.
14. Ropur membranes (accessed on 22.03.2011): http://www.triowater.com/images/pdf/ROPUR_Membranes_4021.pdf.
15. Gros M., Petrović M., Barceló D. Tracing Pharmaceutical Residues of Different Therapeutic Classes in Environmental Waters by Using Liquid Chromatography/Quadrupole-Linear Ion Trap Mass Spectrometry and Automated Library Searching. Anal. Chem. 2009, 81:898-912.
16. Miège C., Choubert J.M., Ribero L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants-Conception of a database and first results. Environ. Pollut. 2009, 157:1721-1726.
17. Le-Minh N., Khan S.J., Drewes J.E., Stuetz R.M., Review Fate of antibiotics during municipal water recycling treatment processes. Water Res. 2010, 44:4295-4323.
18. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
19. Radjenović J., Petrović M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
20. Hirsch R., Ternes T., Haberer K., Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225:109-118.
21. Abuin S., Codony R., Compañó R., Granados M., Prat M.D. Analysis of macrolide antibiotics in river water by solid-phase extraction and liquid chromatography-mass spectrometry. J. Chromatogr. A 2006, 1114:73-81.
22. Maurer M., Escher B.I., Richle P., Schaffner C., Alder A.C. Elimination of β-blockers in sewage treatment plants. Water Res. 2007, 41:1614-1622.
23. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
24. Alexy R., Kümpel T., Kümmerer K. Assessment of degradation of 18 antibiotics in the closed bottle test. Chemosphere 2004, 57:505-512.
25. Mahugo-Santana C., Sosa-Ferrera Z., Torres-Padrón M.E., Santana-Rodríguez J.J. Analytical methodologies for the determination of nitroimidazole residues in biological and environmental liquid samples: a review. Anal. Chim. Acta 2010, 665:113-122.
26. Miao X-S., Yang J-J., Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ. Sci. Technol. 2005, 39:7469-7475.
27. Snyder S.A., Adham S., Redding A.M., Cannon F.S., DeCarolis J., Oppenheimer J., Wert E.C., Yoon Y. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202:156-181.
28. Chon K., Sarp S., Lee S., Lee J.-H., Lopez-Ramirez J.A., Cho J. Evaluation of a membrane bioreactor and nanofiltration for municipal wastewater reclamation: Trace contaminant control and fouling mitigation. Desalination 2011, 272:128-134.
29. Radjenović J., Petrović M., Ventura F., Barceló D. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res. 2008, 42:3601-3610.
30. Gur-Reznik S., Koren-Menashe I., Heller-Grossman L., Rufel O., Dosoretz C.G. Influence of seasonal and operating conditions on the rejection of pharmaceutical active compounds by RO and NF membranes. Desalination 2011, 277:250-256.
31. Snyder S.A., Westerhoff P., Yoon Y., Sedlak D.L., Pharmaceuticals Personal care products, and endocrine disruptors in water: implication for the water industry. Environ. Eng. Sci. 2003, 20:449-469.
32. Bellona C., Drewes J.E., Xu P., Amy G. Factors affecting the rejection of organic solutes during NF/RO treatment: a literature review. Water Res. 2004, 38:2795-2809.